CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies
Shi, Cheng-Cheng2,3; Chen, Tian-Ran3,4,5; Zhang, Qi-Hua6; Wei, Ling-Hua1; Huang, Chao3; Zhu, Ya-Di3; Liu, Hai-Bin4; Bai, Ya-Kun1; Wang, Fang-Jun7; Guo, Wen-Zhi1
刊名RSC ADVANCES
2020-01-23
卷号10期号:7页码:3626-3635
DOI10.1039/c9ra09203j
通讯作者Guo, Wen-Zhi(guowz66@163.com) ; Zhang, Li-Rong(zhanglirongzzu@126.com) ; Ge, Guang-Bo(geguangbo@dicp.ac.cn)
英文摘要Thrombin inhibition therapy is a practical strategy to reduce thrombotic and cardiovascular risks via blocking the formation of blood clots. This study aimed to identify naturally occurring thrombin inhibitors from licorice (one of the most popular edible herbs), as well as to investigate their inhibitory mechanisms. Among all tested licorice constituents, licochalcone A was found as the most efficacious agent against human thrombin (IC50 = 7.96 mu M). Inhibition kinetic analyses demonstrated that licochalcone A was a mixed inhibitor against thrombin-mediated Z-Gly-Gly-Arg-AMC acetate hydrolysis, with a K-i value of 12.23 mu M. Furthermore, mass spectrometry-based chemoproteomic assays and molecular docking simulations revealed that licochalcone A could bind to human thrombin at both exosite I and the catalytic site. In summary, our findings demonstrated that the chalcones isolated from licorice were a new class of direct thrombin inhibitors, also suggesting that licochalcone A was a promising lead compound for developing novel anti-thrombotic agents.
资助项目National Key Research and Development Program of China[2017YFC1700200] ; National Key Research and Development Program of China[2017YFC1702000] ; National Natural Science Foundation of China[81973286] ; National Natural Science Foundation of China[81803489] ; National Natural Science Foundation of China[U1604282] ; National Natural Science Foundation of China[81973393] ; National Natural Science Foundation of China[81922070] ; National Natural Science Foundation of China[81773687] ; Program of Shanghai Academic/Technology Research Leader[18XD1403600] ; Basic and Frontier Technology Research Program of Henan Science and Technology Commission Foundation[142300410039] ; TaiShan Industrial Experts Program[tscy20180234]
WOS关键词TRADITIONAL CHINESE MEDICINE ; BIOACTIVE CONSTITUENTS ; BIOLOGICAL EVALUATION ; CHALCONE DERIVATIVES ; DESIGN ; DISCOVERY ; POTENT ; LICOCHALCONE ; FLAVONOIDS ; ACID
WOS研究方向Chemistry
语种英语
出版者ROYAL SOC CHEMISTRY
WOS记录号WOS:000509900800001
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/281654]  
专题中国科学院上海药物研究所
通讯作者Guo, Wen-Zhi; Zhang, Li-Rong; Ge, Guang-Bo
作者单位1.Zhengzhou Univ, Henan Key Lab Digest Organ Transplantat, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China
2.Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Zhengzhou, Henan, Peoples R China
3.Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai, Peoples R China
4.Dong E E Jiao Co Ltd, Natl Engn Res Ctr Gelatin Based Tradit Chinese Me, Shandong, Peoples R China
5.Zhengzhou Univ, Affiliated Hosp 5, Dept Gastrointestinal Surg, Zhengzhou, Peoples R China
6.Chinese Acad Sci, CAS Key Lab Receptor Res, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, Shanghai, Peoples R China
7.Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China
推荐引用方式
GB/T 7714
Shi, Cheng-Cheng,Chen, Tian-Ran,Zhang, Qi-Hua,et al. Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies[J]. RSC ADVANCES,2020,10(7):3626-3635.
APA Shi, Cheng-Cheng.,Chen, Tian-Ran.,Zhang, Qi-Hua.,Wei, Ling-Hua.,Huang, Chao.,...&Ge, Guang-Bo.(2020).Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies.RSC ADVANCES,10(7),3626-3635.
MLA Shi, Cheng-Cheng,et al."Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies".RSC ADVANCES 10.7(2020):3626-3635.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace